ANZCTR search results

These search results are from the Australian New Zealand Clinical Trials Registry (ANZCTR).

You can narrow down the results using the filters

34128 results sorted by trial registration date.
  • A telehealth model for education and monitoring for early lymphoedema detection and shoulder dysfunction in patients after breast cancer surgery: a pilot study

    The overall aim of this research is to evaluate whether group education and individual monitoring of recovery delivered by telehealth improves follow-up attendance rates compared with usual face to face care for breast cancer patients who have undergone axillary dissection. Who is it for? You may be eligible to join this study if you are a male or female aged 18 years or over and have undergone breast wide local excision or mastectomy and axillary lymph node dissection for breast cancer at Royal Brisbane and Women’s Hospital. To be eligible to receive the telehealth service, patients must be able to access an Internet-enabled computer device within their own home. Study details Four to six weeks after axillary dissection at Royal Brisbane and Women’s Hospital, all patients will receive group lymphoedema education and individual review by a physiotherapist. There will be two groups in this study. One group will be reviewed face-to-face at Royal Brisbane and Women's Hospital (as is standard practice). The other group will be reviewed in their home remotely using telehealth. Attendance rates will be compared between groups, and all participants will be asked to complete a number of questionnaires at 3, 5 and 8 months post breast surgery in order to evaluate lymphoedema symptoms, shoulder function, scar appearance, satisfaction and costs. It is hoped that telehealth can help to address high nonattendance rates at lymphoedema education and review sessions post surgery.

  • TEXT4myBACK’ text message intervention to improve function in people with low back pain

    The aim of the study is to examine the effect of lifestyle-focused program delivered by text message on function in people with non-persistent low back pain. 304 people will be recruited to the study and randomly assigned to receive either the text message intervention or minimal intervention. Those assigned to receive the text messages will receive semi-personalised text messages providing advice, motivation and information to improve education, physical activity, sleep, mood, use or care and medication. Participants will receive 4 text messages every week for 12 weeks. Messages will be sent on randomly selected days and at one of 4 randomly selected time slots. Participants will be eligible to receive certain messages depending on whether they have acute low back pain, sleep issues, are more than moderately active, report taking medication for their low back pain at baseline and have a sedentary job. Health related data will be collected from all participants via online surveys following recruitment, 3 months, 6 months and 12 months after recruitment. The health data collected will be those that are recommended by the key groups in this field of research: The Outcome Measures in Rheumatology Clinical Trials group (OMERACT) The Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT). These will include measures of pain, functional status, patient reported impression of change, generic quality of life, levels of activity, health literacy and health care use and costs.

  • Efficacy of a herbal extract, orally-dosed or topically applied on increasing hair growth and decreasing hair loss in males and females.

    Following preliminary screening via telephone, potential participants will attend the clinic for an information session and will be required to provide their consent for inclusion in the trial. Consenting participants will undergo a health assessment including lifestyle, current medications and medical history; this data will be used for the comprehensive screening and to provide contextual data for the study. Once enrolled in the trial, participants will be randomly allocated to either one of 2 placebo comparator groups or one of two investigational intervention groups. Prior to treatment, participants will undertake various hair assessments including photographs of scalp (unidentifiable), hair comb/count test, hair tug/pull test, densitometry (haircheck®) and also undertake a blood test. Participants will be asked to consume or apply the allocated product according to the dose prescribed and attend the clinic every month for a repeat of baseline measures excluding the blood test. At week 12 participants will be asked to attend the clinic for a final assessment including all measures undertaken at baseline, a final blood test and an exit interview.

  • STIMUlant and osmotic LAXatives in Postoperative Ileus

    Post-operative ileus (POI) is characterized by impairment of bowel motility and is a common complication after major abdominal surgery in general, and after colorectal surgery in particular. The principal features of POI include nausea and vomiting, inability to tolerate diet, significant abdominal distension and delayed passage of flatus and stool. POI as a complication has the largest overall effect on length of postoperative hospitalization. The purpose of this open-label randomized controlled trial is to determine the effectiveness of stimulant and osmotic laxatives on reducing the duration of postoperative ileus following bowel resection in an optimized Enhanced Recovery After Surgery (ERAS) setting. We hypothesize that in an optimized ERAS setting, using a combination of stimulant and osmotic laxatives post-operatively will result in a reduction in the duration of postoperative Ileus.

  • Evaluation of a Mindfulness-Based program for people with Multiple Sclerosis

    The aim of this research project is to evaluate an online mindfulness-based program for people with Multiple Sclerosis. The eight-week program involves five online modules, and mindfulness meditation practice, which will be supplemented by meditation audio-guides and weekly telephone calls with a psychologist. We hypothesize that people with MS who complete this program will improve in symptoms of depression (primary outcome), anxiety, fatigue, and health-related quality of life.

  • Sleepwell: A Trial to Improve Sleep During Chemotherapy for Breast Cancer

    This study aims to test the effectiveness of cognitive behaviour therapy in combination with light therapy compared to relaxation audio. Who is it for? You may be eligible for this study if you are a woman aged over 18, have a diagnosis of primary breast cancer (any stage) and are receiving (or will receive) chemotherapy. Study details Participants will be randomised (by chance) to one of two treatments. One treatment (the Intervention group) is a cognitive behavioural therapy session in addition to use of Light glasses to be worn for 30 minutes each morning. The other group (the Control group) will receive relaxing audio tracks by email. The Control group will receive the information provided to the Intervention group after 3 months. All participants (both groups) will fill out a sleep diary, fill out a questionnaire and wear a watch that measures sleep. It is hoped that this research will help us understand whether a combined behavioural and bright light intervention can reduce sleep disruption and fatigue during chemotherapy for breast cancer and provide a basis for expanding the treatment to people with other types of cancer.

  • REsolution of LEft VENTtricular thrombus (RELEVENT)

    Left ventricular mural thrombus, which is identified in ~5% of patients after anterior ST elevation myocardial infarction, is a major risk factor for stroke. Anti-coagulation with warfarin is the currently recommended treatment. Direct oral anticoagulants (DOACs) such as factor Xa inhibitors apixaban and rivaroxaban, or the direct thrombin inhibitor, dabigatran, have a number of advantages over warfarin, and are an alternative treatment though not currently approved for this indication. There is currently limited randomised evidence to guide management of LV thrombus. This multi-center clinical trial will compare effects of DOACs versus warfarin on LV thrombus resolution and incidence of CV death, stroke, systemic embolism and major bleeding over a 3-month treatment period. Participants will be followed up annually for a period of 3 years to determine long-term health and participant reported outcomes.

  • Minimally Invasive Umbilical Ileostomy Versus Traditional Ileostomy - A Randomised control study targeting patient quality of life

    The purpose of the study is to investigate the impact that ileostomy site placement has on patient quality of life. This study compares the traditional ileostomy in the right lower quadrant to a minimally invasive ileostomy formed through the umbilicus. The hypothesis is that a minimally invasive ileostomy through the umbilicus is better for the patient as: - There is no damage to the muscle when forming this umbilicus - It's midline position makes it easier for patient's to manage - There is not an extra incision made for this (umbilicus is a common site for port placement during laparoscopic (keyhole) surgery - Patient's are able to sleep on either side due to the midline position

  • Assessment of fatigue in motor vehicle drivers with and without sleep apnoea.

    The purpose of this study is to determine whether drowsiness during driving can be detected by using eye blink measures. In particular we are interested in determining whether eye blink measures differ between individuals with sleep apnoea and healthy individuals during their regular driving. Sleep apnoea participants will be matched with healthy participants in respect to age (within 5 years) and gender, It is anticipated that sleep apnoea group will be more tired and this will be demonstrated in their eye blink measures. The study is observational., The main outcome measures are eye blinks, self-reported and measured sleepiness, reaction times and driving habits.

  • Project GRIT (Growth, Resilience, Insights, Thrive): a pilot intervention study to prevent childhood obesity

    Project GRIT (Growth, Resilience, Insights, Thrive) is a single arm pilot intervention study for children. The program is 12-weeks in length and involves exercise (high intensity interval training), healthy eating and psychological intervention (mindfulness and emotional freedom techniques) for children. The key research question of Project GRIT is: what is the effectiveness of a multidisciplinary intervention involving small-group exercise training and dietary education on metabolic fitness, body composition, cognitive performance, and diet quality in sedentary children aged 9 – 15 years living on the Gold Coast, Australia.

Tags:
  • Finding clinical trials